These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9471916)

  • 21. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
    Ekenel M; Iwamoto FM; Ben-Porat LS; Panageas KS; Yahalom J; DeAngelis LM; Abrey LE
    Cancer; 2008 Sep; 113(5):1025-31. PubMed ID: 18618509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?
    Restrepo A; Raez LE; Byrne GE; Johnson T; Ossi P; Benedetto P; Hamilton K; Whitcomb CC; Cassileth PA
    Crit Rev Oncog; 1998; 9(3-4):269-73. PubMed ID: 10201631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radiation therapy of CNS lymphoma].
    Shimizu T; Nishimura T; Teshima T; Kaneko M
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2676-83. PubMed ID: 2277218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.
    Davidson KL; Devaney MB; Tighe JE; Rogers SY; Dunlop DJ; Mackie MJ; Thomas RV; Johnson PR;
    Haematologica; 2003 Dec; 88(12):1366-71. PubMed ID: 14687989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas.
    Bremer K
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
    Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S
    Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
    Mason JO; Fischer DH
    Ophthalmology; 2003 Jun; 110(6):1241-4. PubMed ID: 12799254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
    Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
    Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. To protect and defend: central nervous system prophylaxis in patients with non-Hodgkin's lymphoma.
    Lim HY; Thiel E; Glantz MJ
    Curr Opin Oncol; 2008 Sep; 20(5):495-501. PubMed ID: 19106650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Meningosis-prophylaxis in the treatment of acute lymphoblastic leukemia and of non-Hodgkin's lymphomas (author's transl)].
    Wehinger H
    Strahlentherapie; 1977 Apr; 153(4):236-40. PubMed ID: 266295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma.
    Chua SL; Seymour JF; Streater J; Wolf MM; Januszewicz EH; Prince HM
    Leuk Lymphoma; 2002 Sep; 43(9):1783-8. PubMed ID: 12685832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Incidence of lymphoma cells in the bone marrow and peripheral blood in patients with non-Hodgkin's type lymphoma].
    Rajić M; Vidaković B; Bojić P
    Srp Arh Celok Lek; 1989; 117(1-2):27-37. PubMed ID: 2799547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal donor lymphocyte infusion for the treatment of suspected refractory lymphomatous meningitis: a case report.
    Meuleman N; Ahmad I; Duvillier H; Lemort M; Bennani J; Martiat M; Lagneaux L; Bron D
    Eur J Haematol; 2006 Dec; 77(6):523-6. PubMed ID: 17042768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
    Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.